JUL 12, 2017 3:50 PM PDT

Bipolar Disorder: Men and Women Have Different Biomarkers

WRITTEN BY: Xuan Pham

According to a new study, men and women have different immune responses to bipolar disorder. The findings have big implications for future diagnostic tests, as well as treatment for men and women with this disease.

Image credit: Pixabay.com

Researchers have long observed that men and women experience the effects of bipolar disorder differently. In particular, women with the condition experience depressive episodes, mixed mania, and rapid cycling more often than their male counterparts. Women are also more likely than men to experience post-traumatic stress disorder, migraines, and disruptions in their sleep pattern that lead to dysregulated mood. Bipolar prevalence also varies between the sexes, with bipolar II more commonly seen in women than men.

Penn State researchers also note that bipolar disorder also alters the immune system, causing low but potentially harmful inflammation in the brain. "When a person has mania or depression, certain parts of their brain are affected," said Erika Saunders, professor and chair of psychiatry at Penn State College of Medicine, and the study’s senior author. "For example, the hippocampus, which is important in memory formation, shrinks, and the connections between different parts of the brain are affected. We think that inflammation is playing a role in some of those changes that are then associated with poor functioning in bipolar disorder."

Given these observations, Saunders’ team hoped to identify some immune differences that would distinguish bipolar in men versus women. They analyzed immune biomarkers for 27 participants with bipolar disorder versus 31 participants who were otherwise healthy. Specifically, the team measured two immune system factors, zinc and neopterin, both of which are involved in inflammatory responses.

When the data were compared between the healthy versus the sick group, the team found small differences in zinc levels – people with bipolar disorder seemed to have lower levels of zinc than healthy people.

However, when the researchers looked at differences between the genders, more striking differences emerged for both biomarkers. In particular, both biomarkers seemed to be linked to the severity of depression or mania and the person’s gender. For example, women who had high concentrations of zinc were more likely to experience worse depression, whereas men with high concentrations of neopterin were more likely to experience worse mania.

Of note, the results deviate slightly from previous studies which found zinc deficiency to be associated with depression. Saunders and her team plan on investigating this surprising result, and they suspect zinc levels may be different in blood versus the brain. And as such, the authors are quick to caution against any self-medication with zinc supplements.

“What we are aiming for ultimately as a field and as a research group is to have a blood marker that we can use in the clinic that will help us predict when someone is developing a bipolar episode, and conversely when a treatment is working," Saunders said. "The work that we're doing in conjunction with the work of others across the country is understanding each individual factor that can then be put together in a larger way."

The results of the study suggest there are differences at the cellular level for men and women with bipolar disorder. And if these biological differences can be further teased apart, we may be able to improve diagnosis and treatment for people with the disorder.

Additional source: Penn State

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
DEC 18, 2019
Clinical & Molecular DX
DEC 18, 2019
Germs don't stand a chance with new AI-powered diagnostic platform
We are steadily losing our edge in the war against infectious bacteria. A huge surge in antibiotic resistance is threate ...
JAN 07, 2020
Clinical & Molecular DX
JAN 07, 2020
Saliva Test for Early Detection of Mouth and Throat Cancer
“OPC is one of the fastest rising cancers in Western countries due to increasing HPV-related incidence, especially ...
JAN 28, 2020
Clinical & Molecular DX
JAN 28, 2020
Protein complex discovered as first biomarker of PTSD
  Researchers at the Centre for Addiction and Mental Health (CAMH) and the Canadian Institutes of Health Research ( ...
APR 01, 2020
Clinical & Molecular DX
APR 01, 2020
One dollar kit diagnoses COVID-19 in 10 minutes
Researchers have begun efficacy testing for a new SARS-CoV-2 diagnostic kit that claims to be able to test for COVID-19 ...
APR 13, 2020
Cancer
APR 13, 2020
The Unexpected Role of Mono in Cancer Progression
In the past, the go-to drugs have always been small molecules. These small molecules would interact with the cell and ac ...
APR 23, 2020
Clinical & Molecular DX
APR 23, 2020
FDA Approves At-Home Sample Collection Diagnostic Test for COVID-19
The coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). M ...
Loading Comments...